bibliographic entry 2231722 [be/2231722]
https://w3id.org/oc/corpus/be/2231722

is a
content
  • Higgs BW RP, Blake-Haskins JA, Zhu W, Morehouse C, Brohawn PZ, Rebelatto MC, Yao Y, Jin X, Shi L, Ranade K. High tumoral IFNy mRNA, PD-L1 protein, and combined IFNy mRNA/PDL1 protein expression associates with response to durvalumab (anti-PD-L1) monotherapy in NSCLC patients. Abstract Book of the 40th ESMO Congress (ESMO 2015) Vienna, Austria. 2015(15 LBA).
references